RPE adenocarcinoma arising from a congenital hypertrophy of the RPE (CHRPE) treated with proton therapy

Klin Monbl Augenheilkd. 2014 Apr;231(4):411-3. doi: 10.1055/s-0034-1368287. Epub 2014 Apr 25.

Authors

A P Moulin¹, L Zografos¹, A Schalenbourg¹

Affiliation

¹ Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, FAA, Lausanne, Switzerland.

PMID: 24771179
DOI: 10.1055/s-0034-1368287

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / etiology*
Adenocarcinoma / pathology
Adenocarcinoma / radiotherapy*
Humans
Hypertrophy / congenital
Hypertrophy / pathology
Hypertrophy / radiotherapy
Male
Middle Aged
Proton Therapy*
Radiotherapy, High-Energy / methods*
Retinal Neoplasms / etiology*
Retinal Neoplasms / pathology
Retinal Neoplasms / radiotherapy*
Retinal Pigment Epithelium / pathology*
Retinal Pigment Epithelium / radiation effects
Treatment Outcome

Substances

Protons